NASET News Alert

More People Are Looking for ADHD Medication in 2023 Than Ever Before—Here’s Why

March 03, 2023

The ongoing Adderall shortage divulges a variety of information about the healthcare landscape of the United States. Perhaps most interestingly, a noticeable uptick in ADHD (attention-deficit/hyperactivity disorder) diagnoses. In October, the Food & Drug Administration confirmed a limited supply of Adderall, a commonly prescribed ADHD medication.1 Consequently, alternative ADHD medications became more scarce as well. The reason for the shortage in medication is not supply chain related, as many previously assumed. Instead, it’s the increase in diagnoses, which have led to a greater demand for the medication than manufacturers can produce. To understand the steep rise in ADHD diagnoses, a detailed look at public awareness, social media impact, and side effects of the COVID-19 pandemic is required. Read More